Indian Osimertinib Exporters: Complete Supplier Ranking with Market Share — 15 Manufacturers (2026) — TransData Nexus

Q: Who is the largest osimertinib supplier from India?

NIVIRA EXPORTS is the largest osimertinib exporter from India with a 31.9% market share and export value of $347.1K.

Q: How many osimertinib suppliers are there in India?

There are 15 active osimertinib exporters in India, collectively shipping $1.1M worth of osimertinib across 130 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top osimertinib suppliers from India?

The top 5 osimertinib suppliers from India — NIVIRA EXPORTS, NU HOSPITALS PRIVATE LIMITED, IKRIS PHARMA NETWORK PRIVATE LIMITED, MATSUN EXPORTS, YARAPMIN PHARMA PRIVATE LIMITED — together control 60.6% of total osimertinib export value from India.

Suresh Sormare

Osimertinib

India Pharmaceutical Trade Intelligence

$1.1M15 Suppliers8 CountriesHS 30049099

ExportsIndia → BRAZIL56.9%India → UNITED KINGDOM24.2%

ImportsSWEDEN → India$217.6M GERMANY → India$346.0K

#1 Supplier: NIVIRA EXPORTS #1 Buyer: INDIRA GANDHI

Osimertinib Suppliers from India (2026) — 15 Exporters, $1.1M Market | TransData Nexus | TransData Nexus

Who Exports Osimertinib from India — 15 Suppliers Behind a $1.1M Market

India's osimertinib export market is supplied by 15 active exporters who collectively shipped $1.1M across 130 shipments. NIVIRA EXPORTS leads with a 31.9% market share, followed by NU HOSPITALS PRIVATE LIMITED and IKRIS PHARMA NETWORK PRIVATE LIMITED. The top 5 suppliers together control 60.6% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Osimertinib Suppliers & Exporters — 15 manufacturers, $1.1M export market, top destinations and formulations — Osimertinib supplier data — 15 exporters · $1.1M market · 130 shipmentsTransData Nexus · Indian Customs Data

Top Osimertinib Exporters from India — Ranked by Export Value

NIVIRA EXPORTS is the leading osimertinib exporter from India, holding a 31.9% share of the $1.1M market across 130 shipments from 15 exporters. The top 5 suppliers — NIVIRA EXPORTS, NU HOSPITALS PRIVATE LIMITED, IKRIS PHARMA NETWORK PRIVATE LIMITED, MATSUN EXPORTS, YARAPMIN PHARMA PRIVATE LIMITED — collectively control 60.6% of total export value, indicating a moderately concentrated market. Individual shares are: NIVIRA EXPORTS (31.9%), NU HOSPITALS PRIVATE LIMITED (12.0%), IKRIS PHARMA NETWORK PRIVATE LIMITED (7.0%), MATSUN EXPORTS (5.2%), YARAPMIN PHARMA PRIVATE LIMITED (4.5%).

Top Osimertinib Exporters from India

Ranked by export value · 15 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Osimertinib Exporters from India — Ranked by Export Value. 15 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Osimertinib exporters

Certification and compliance status for top Osimertinib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
NIVIRA EXPORTS	Not Listed	Yes	Yes	Not verified	Nivira Exports collaborates with manufacturers accredited with WHO-GMP, EU-GMP,

TransData Nexus reviewed the regulatory standing of 1 leading Osimertinib exporters from India. 0 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Osimertinib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The presence of Genome Valley, India's first biotech cluster, further enhances Hyderabad's capabilities in research and development. This robust infrastructure makes Hyderabad a prime location for sourcing high-quality APIs, including Osimertinib.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its expertise in pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with companies like Zydus Cadila and Torrent Pharmaceuticals headquartered in this region. The well-established infrastructure and regulatory compliance make this cluster ideal for sourcing finished formulations of Osimertinib.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. Mumbai, being India's financial capital, offers extensive logistics and shipping facilities, facilitating efficient international distribution. This region's strategic location and infrastructure support the export of pharmaceuticals, including Osimertinib, to global markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Osimertinib exporters from India

June 2025

M&A

Torrent Pharmaceuticals Limited — Torrent Pharma acquires controlling stake in J.B. Chemicals & Pharmaceuticals

Torrent Pharmaceuticals Limited announced the acquisition of a 46.39% equity stake in J.B. Chemicals & Pharmaceuticals from KKR, followed by a merger of the two entities. This strategic move aims to strengthen Torrent's presence in the Indian pharmaceutical market and expand its contract development and manufacturing organization (CDMO) capabilities.

Impact: While this acquisition does not directly involve the top Osimertinib exporters, it reflects a trend of consolidation in the Indian pharmaceutical industry, potentially affecting market dynamics and competitive landscapes for Osimertinib exports.

December 2025

Capacity Expansion

Windlas Biotech Limited — Windlas Biotech ventures into injectable product manufacturing

Windlas Biotech Limited announced its strategic expansion into the injectables segment, aiming to diversify its product portfolio beyond oral solids and liquids. The new injectables facility has received customer approvals and will cater to all three business verticals: CDMO, trade generics, and exports.

Impact: This expansion signifies a growing trend among Indian pharmaceutical companies to enhance their manufacturing capabilities, which could influence the competitive environment for Osimertinib exporters.

Common Questions — Osimertinib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which osimertinib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, NIVIRA EXPORTS leads with 52 recorded shipments worth $347.1K. NU HOSPITALS PRIVATE LIMITED (4 shipments) and IKRIS PHARMA NETWORK PRIVATE LIMITED (17 shipments) are also established high-volume exporters.

Q How many osimertinib manufacturers are there in India?

India has 15 active osimertinib exporters with a combined export market of $1.1M across 130 shipments to 8 countries. The top 5 suppliers hold 60.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for osimertinib from India?

Average FOB unit price: $2290.13 per unit, ranging from $0.02 to $5448.41. Average shipment value: $8.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Osimertinib

Osimertinib

Who Exports Osimertinib from India — 15 Suppliers Behind a $1.1M Market

Top Osimertinib Exporters from India — Ranked by Export Value

Top Osimertinib Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Torrent Pharmaceuticals Limited — Torrent Pharma acquires controlling stake in J.B. Chemicals & Pharmaceuticals

Windlas Biotech Limited — Windlas Biotech ventures into injectable product manufacturing

Common Questions — Osimertinib Suppliers from India

Q Which osimertinib supplier from India is the most reliable for bulk orders?

Q How many osimertinib manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for osimertinib from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Piramal Pharma Limited — Piramal Pharma addresses challenges in CDMO segment

Analysis Methodology